You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stivarga

Showing 1 - 25 of 129
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Called RegoFlex EU, to Learn More About Use of Stivarga at

Completed
  • Metastatic Colorectal Cancer
  • Retrospective patient chart review
  • Whippany, New Jersey
    Many locations
Jan 24, 2023

Regorafenib Post-marketing Surveillance in Japan

Completed
  • Gastrointestinal Stromal Tumors
  • Regorafenib (Stivarga, BAY73-4506)
  • Multiple Locations, Japan
    (unnamed)
Mar 21, 2022

Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • (no location specified)
Oct 13, 2023

Learn More About Order of Different Treatments and Their Effects

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • (no location specified)
Nov 13, 2023

Learn More About Long-Term Responses to Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Whippany, New Jersey
    Bayer
Sep 1, 2023

Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
    University of Miami
Jan 3, 2023

MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 17, 2023

Microsatellite Stable Metastatic Colorectal Cancer Trial in Shanghai (Regorafenib, Toripalimab, High/low-dose radiotherapy)

Recruiting
  • Microsatellite Stable Metastatic Colorectal Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 19, 2023

Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2023

Hepatocellular Carcinoma Trial in Winston-Salem (TheraBionic, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Oct 26, 2022

Colo-rectal Cancer, Metastatic Cancer Trial in Besançon, Dijon, Montbéliard (Regorafenib, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Colo-rectal Cancer
  • Metastatic Cancer
  • Besançon, France
  • +2 more
Jan 24, 2023

Colorectal Cancer Trial in Omaha (XL092, Atezolizumab, Regorafenib)

Recruiting
  • Colorectal Cancer
  • Omaha, Nebraska
    Exelixis Clinical Site #1
Jul 26, 2022

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Active, not recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Feb 2, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)

Terminated
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Kashiwa (Regorafenib,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
May 23, 2022

Regorafenib, Raltitrexed, Colorectal Tumors Trial (Regorafenib, Raltitrexed)

Not yet recruiting
  • Regorafenib
  • +3 more
  • (no location specified)
Jun 24, 2022

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Colorectal Cancer, Colorectal Cancer Metastatic Trial in United States (Pembrolizumab, Regorafenib)

Active, not recruiting
  • Colorectal Cancer
  • Colorectal Cancer Metastatic
  • Duarte, California
  • +3 more
Aug 5, 2022

Thyroid Cancer Trial in New Haven, Boston (Regorafenib)

Recruiting
  • Thyroid Cancer
  • New Haven, Connecticut
  • +1 more
Feb 18, 2022

Metastatic Colorectal Cancer Trial in France (Regorafenib then Trifluridine/Tipiracil, Trifluridine/Tipiracil then Regorafenib)

Recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib then Trifluridine/Tipiracil
  • Trifluridine/Tipiracil then Regorafenib
  • Bouge, Belgium
  • +37 more
Dec 14, 2022

Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)

Recruiting
  • Advanced Cancer
  • Solid Tumor
  • Helsinki, Uusimaa, Finland
  • +2 more
Jun 8, 2022

Colorectal Cancer; Lung Cancer Trial in Orange, Hsinchu, Taichung (TATE and pembrolizumab, TAS-102 pill, Regorafenib Pill)

Recruiting
  • Colorectal Cancer; Lung Cancer
  • TATE and pembrolizumab
  • +2 more
  • Orange, California
  • +2 more
Apr 13, 2022

Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Hyderabad, Andhra Pradesh, India
  • +12 more
Jan 13, 2023